Skip to main content

Table 1 Baseline characteristics in patients with and without confirmed CDI diagnosis.

From: Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

 

N (%) or median (IQR)

Variable

CDI-positive

(n =9)

CDI-negative

(n = 6)

Age (years)

62 (50-86)

64 (59-65)

Peak creatinine (μmol/L)

  

< 100

8 (89)

6 (100)

100-199

0

0

≥200

1 (11)

0

Peak leukocyte count × 109/L

< 10.0

0

1 (17)

10.0 - 19.9

2 (22)

2 (22)

≥20.0

7 (78)

3 (50)

Number of stools/day

4 (0-6)

5 (3-6)

Fever (first 48 hours)

3 (33)

5 (83)

Ileus

1 (11)

0

Initially prescribed dosage

  

125 mg

5 (56)

4 (67)

250 mg

3 (33)

1 (17)

500 mg

1 (11)

1 (17)

Days of treatment

6 (5-15)

5 (4-10)